Front Row Advisors LLC Edwards Lifesciences Corp Transaction History
Front Row Advisors LLC
- $277 Million
- Q4 2024
A detailed history of Front Row Advisors LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Front Row Advisors LLC holds 240 shares of EW stock, worth $18,249. This represents 0.01% of its overall portfolio holdings.
Number of Shares
240
Previous 240
-0.0%
Holding current value
$18,249
Previous $15,000
13.33%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding EW
# of Institutions
1,379Shares Held
453MCall Options Held
6.71MPut Options Held
3.17M-
Vanguard Group Inc Valley Forge, PA69.1MShares$5.26 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.88 Billion0.11% of portfolio
-
State Street Corp Boston, MA25.8MShares$1.96 Billion0.08% of portfolio
-
Jpmorgan Chase & CO New York, NY14.9MShares$1.13 Billion0.09% of portfolio
-
Geode Capital Management, LLC Boston, MA13.6MShares$1.04 Billion0.08% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $47B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...